PT1259498E - Derivados do 8,8a-di-hidroindeno[1,2-d]tiazole substituidos na posicao 8a, processo para a sua preparacao e sua utilizacao como medicamentos, p. ex. como anorecticos - Google Patents
Derivados do 8,8a-di-hidroindeno[1,2-d]tiazole substituidos na posicao 8a, processo para a sua preparacao e sua utilizacao como medicamentos, p. ex. como anorecticosInfo
- Publication number
- PT1259498E PT1259498E PT01929342T PT01929342T PT1259498E PT 1259498 E PT1259498 E PT 1259498E PT 01929342 T PT01929342 T PT 01929342T PT 01929342 T PT01929342 T PT 01929342T PT 1259498 E PT1259498 E PT 1259498E
- Authority
- PT
- Portugal
- Prior art keywords
- anorectics
- derivatives
- tiazole
- dihydroindene
- medicines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Fuses (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10008275 | 2000-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1259498E true PT1259498E (pt) | 2005-02-28 |
Family
ID=7631989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01929342T PT1259498E (pt) | 2000-02-23 | 2001-02-12 | Derivados do 8,8a-di-hidroindeno[1,2-d]tiazole substituidos na posicao 8a, processo para a sua preparacao e sua utilizacao como medicamentos, p. ex. como anorecticos |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6403624B1 (pt) |
| EP (1) | EP1259498B1 (pt) |
| JP (1) | JP4898052B2 (pt) |
| KR (1) | KR20020079891A (pt) |
| CN (1) | CN1195747C (pt) |
| AT (1) | ATE283265T1 (pt) |
| AU (1) | AU781003B2 (pt) |
| BR (1) | BR0108605A (pt) |
| CA (1) | CA2400698A1 (pt) |
| CZ (1) | CZ20022838A3 (pt) |
| DE (1) | DE50104600D1 (pt) |
| EE (1) | EE200200466A (pt) |
| ES (1) | ES2231482T3 (pt) |
| HK (1) | HK1055117A1 (pt) |
| HR (1) | HRP20020688A2 (pt) |
| HU (1) | HUP0300140A3 (pt) |
| IL (1) | IL151327A0 (pt) |
| MX (1) | MXPA02007021A (pt) |
| NO (1) | NO20023978L (pt) |
| NZ (1) | NZ520926A (pt) |
| PL (1) | PL357547A1 (pt) |
| PT (1) | PT1259498E (pt) |
| RU (1) | RU2261860C2 (pt) |
| SK (1) | SK12162002A3 (pt) |
| WO (1) | WO2001062746A1 (pt) |
| YU (1) | YU56302A (pt) |
| ZA (1) | ZA200206487B (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10142660A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE10142659A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2527360B1 (en) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| CA2741125A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
| AU2011218830B2 (en) | 2010-02-25 | 2014-07-24 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EA201690035A1 (ru) | 2011-02-25 | 2016-05-31 | Мерк Шарп Энд Домэ Корп. | Новые циклические производные азабензимидазола, используемые в качестве антидиабетических агентов |
| EP3366698A1 (en) | 2011-03-01 | 2018-08-29 | Synergy Pharmaceuticals Inc. | Guanylate cyclase c agonists |
| WO2014022528A1 (en) | 2012-08-02 | 2014-02-06 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| WO2014130608A1 (en) | 2013-02-22 | 2014-08-28 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| EP2970119B1 (en) | 2013-03-14 | 2021-11-03 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| EA201592263A1 (ru) | 2013-06-05 | 2016-05-31 | Синерджи Фармасьютикалз, Инк. | Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| EP3551176A4 (en) | 2016-12-06 | 2020-06-24 | Merck Sharp & Dohme Corp. | ANTIDIABETIC HETEROCYCLIC COMPOUNDS |
| EP3558298A4 (en) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | ANTIDIABETIC SPIROCHROMAN COMPOUNDS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2640358A1 (de) | 1976-09-08 | 1978-03-16 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
| GB9517381D0 (en) * | 1995-08-24 | 1995-10-25 | Pharmacia Spa | Aryl and heteroaryl piperazine derivatives |
| DE19844547C2 (de) * | 1998-09-29 | 2002-11-07 | Aventis Pharma Gmbh | Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE19908539A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
2001
- 2001-02-12 YU YU56302A patent/YU56302A/sh unknown
- 2001-02-12 CN CNB018054919A patent/CN1195747C/zh not_active Expired - Fee Related
- 2001-02-12 EE EEP200200466A patent/EE200200466A/xx unknown
- 2001-02-12 NZ NZ520926A patent/NZ520926A/en unknown
- 2001-02-12 WO PCT/EP2001/001499 patent/WO2001062746A1/de not_active Application Discontinuation
- 2001-02-12 IL IL15132701A patent/IL151327A0/xx unknown
- 2001-02-12 MX MXPA02007021A patent/MXPA02007021A/es active IP Right Grant
- 2001-02-12 BR BR0108605-7A patent/BR0108605A/pt not_active IP Right Cessation
- 2001-02-12 PT PT01929342T patent/PT1259498E/pt unknown
- 2001-02-12 EP EP01929342A patent/EP1259498B1/de not_active Expired - Lifetime
- 2001-02-12 DE DE50104600T patent/DE50104600D1/de not_active Expired - Lifetime
- 2001-02-12 CA CA002400698A patent/CA2400698A1/en not_active Abandoned
- 2001-02-12 JP JP2001562528A patent/JP4898052B2/ja not_active Expired - Fee Related
- 2001-02-12 ES ES01929342T patent/ES2231482T3/es not_active Expired - Lifetime
- 2001-02-12 RU RU2002125460/04A patent/RU2261860C2/ru not_active IP Right Cessation
- 2001-02-12 SK SK1216-2002A patent/SK12162002A3/sk unknown
- 2001-02-12 CZ CZ20022838A patent/CZ20022838A3/cs unknown
- 2001-02-12 AT AT01929342T patent/ATE283265T1/de not_active IP Right Cessation
- 2001-02-12 PL PL01357547A patent/PL357547A1/xx not_active Application Discontinuation
- 2001-02-12 KR KR1020027011001A patent/KR20020079891A/ko not_active Application Discontinuation
- 2001-02-12 AU AU56153/01A patent/AU781003B2/en not_active Ceased
- 2001-02-12 HU HU0300140A patent/HUP0300140A3/hu unknown
- 2001-02-23 US US09/790,911 patent/US6403624B1/en not_active Expired - Lifetime
-
2002
- 2002-08-14 ZA ZA200206487A patent/ZA200206487B/en unknown
- 2002-08-21 NO NO20023978A patent/NO20023978L/no not_active Application Discontinuation
- 2002-08-22 HR HRP20020688 patent/HRP20020688A2/hr not_active Application Discontinuation
-
2003
- 2003-10-15 HK HK03107412A patent/HK1055117A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1259498E (pt) | Derivados do 8,8a-di-hidroindeno[1,2-d]tiazole substituidos na posicao 8a, processo para a sua preparacao e sua utilizacao como medicamentos, p. ex. como anorecticos | |
| BR0309242A (pt) | Derivados de acil-4-carboxifenil-uréia, processo para a sua preparação e sua aplicação | |
| BR0017030A (pt) | Derivados de tiazolilamida | |
| BR0312513A (pt) | Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos | |
| ME00376B (me) | DIHIDROPTERIDINONI, POSTUPAK ZA NJlHOVO PRIPREMANJE I NJlHOVA PRIMJENA KAO LIJEK | |
| BRPI0407387A (pt) | Derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona substituìdos por nitrogênio, processos para a sua preparação e sua aplicação com medicamento | |
| BR0317283A (pt) | Derivados heterocìclicos de flúor-glicosìdeo, medicamentos contendo estes compostos e seu uso | |
| BR0316605A (pt) | Derivados de fluorglicosìdeos aromáticos, medicamentos contendo estes compostos e sua aplicação | |
| BRPI0407507A (pt) | derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona, processos para sua preparação de sua aplicação como medicamento | |
| BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
| BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
| MEP9309A (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same | |
| BR0013311A (pt) | Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor | |
| NO20023977D0 (no) | 8,8A-dihydro-indeno(1,2-D)tiazolderivater med en sulfonamid- eller sulfon substituert i 2-posisjonen, en fremgangsmåte forfremstilling derav og anvendelse som et legemiddel | |
| BR0208534A (pt) | Processo para preparação de 4,6-diaminopirimido[5,4-d]pirimidinas | |
| YU63696A (sh) | Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova | |
| BRPI0408689B8 (pt) | derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor | |
| BR9912151A (pt) | Tiazolidin-2-ilideno-aminas policìclicas, processo para a sua preparação e sua aplicação como medicamentos | |
| BR0013313A (pt) | Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda | |
| BR0008510A (pt) | Sistemas policìclicos de 2-amino-tiazol, processo para a sua preparação e medicamento contendo estes compostos | |
| AR022542A1 (es) | Derivados de piperidina y piperazina | |
| PT1183247E (pt) | Sistemas tiazole policiclicos e sua utilizacao como anorecticos | |
| BR0008681A (pt) | Derivados de 3-amino -3-arilpropan-1-ol, processo para sua obtenção, medicamento e seu uso | |
| EE200200465A (et) | Asendatud 8,8a-dihüdro-3aH-indeno[1,2-d]tiasoolid, nende valmistamismeetod ja kasutamine ravimitena | |
| BR0017379A (pt) | Composto polissacarìdeo, método para a obtenção do composto, uso do composto e preparação farmacêutica |